Merrimack Pharmaceuticals Inc. (MACK) Dropped -6.06% or -0.67 To Price $10.39 On Monday


Merrimack Pharmaceuticals Inc. (MACK) dropped -6.06% or -0.67 to $10.39. It is nearly 340195 shares traded, which is 195.12% compare to the average total volume 174353. The market cap of MACK is $138.53 million. The year to date change is 3.85%. The 52 week price range is from $10.04 to $48.6. Price of MACK have changed 7.90% during last week. It have changed 4.54% over last month, -15.57% over last 3 months, -22.66% over last 6 months and -69.86% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MACK is 11.17. It is 7.51% above current price. The 200-day Moving Averages for MACK is 15.07. It is 45.04% above current price. The 52-week High is 48.6. It is 367.76% from the current price. The 52-week Low is 10.04. It is -3.37% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MACK is 10.8 on 2017-12-15. Short % to float is 39.60%. There are some statistics of MACK. It is has market cap $138.53 million. The share outstanding is 13.33 million. The average volume is 174353. The percent of top 15 Institution holding is 42.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MACK is -786.00%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MACK is 286.18%.


Tags:

Share this post